
Effect of hemocarboperfusion on renal function in diabetic patients with progressive nephromicroangiopathy
Author(s) -
В. В. Трусов,
Т. Е. Чернышева,
S. A. Marysin
Publication year - 1988
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99645
Subject(s) - medicine , hemodialysis , diabetic nephropathy , renal function , kidney disease , chronic renal failure , extracorporeal , anabolism , chronic renal disease , diabetes mellitus , intensive care medicine , urology , kidney , endocrinology
Currently, in the treatment of some forms of chronic kidney disease and chronic renal failure is used method of intensive detoxification therapy - extracorporeal hemocarboperfusion (hemosorption). Of particular interest is the use of hemocarboperfusion in diabetic patients with diabetic nephromicroangiopathy, which is known to be one of the most serious complications of the underlying disease. Existing treatments (angioprotectors, disaggregants, anticoagulants, anabolic steroids, oxygenobarone therapy, hemodialysis) can not stop the progression of diabetic nephromycoangiopathy and are not effective in the development of chronic renal failure.